We report on a secretory phospholipase A 2 (sPLA 2 ) associated with membrane-enriched fractions prepared from hemocytes of the tobacco hornworms, Manduca sexta. Virtually no PLA 2 activity was detected in serum of immunologically naive or bacterially challenged hornworms. PLA 2 activity was detected in cytosolic and membrane-enriched fractions prepared from hemocytes. PLA 2 activity in the cytosolic fraction (1.2 pmol/mg/h) was approximately 4-fold greater than in the membrane-enriched fraction. The cytosol-associated PLA 2 activity was strongly inhibited in reactions conducted in the presence of the specific cytosolic PLA 2 inhibitor methylarachidonyl fluorophosphate (MAFP) but not in the presence of the sPLA 2 inhibitor pbromophenacyl bromide (BPB). Conversely, the membrane-associated PLA 2 activity was inhibited in reactions conducted in the presence of BPB but not in the presence of MAFP. While the cytosol-associated PLA 2 was independent of calcium, the membrane-associated sPLA 2 required calcium for full catalytic activity. Hornworms treated with either BPB, MAFP or the glucocorticosteroid dexamethasone were severely impaired (by 50 to 80% relative to controls) in their ability to form nodules in reaction to bacterial challenge. However, the immune-impairing influence of the inhibitors was reversed by treating larvae with arachidonic acid, a precursor for eicosanoid biosynthesis. We infer that the biological significance of the sPLA 2 (as well as the previously characterized cytosolic PLA 2 ) relates to hydrolysis of polyunsaturated fatty acids from cellular phospholipids. Moreover, this enzyme may be the target of immunity-impairing factors from the bacterium Xenorhabdus nematophila. The fatty acids serve as precursors for the generation of eicosanoids responsible for mediating and coordinating cellular immune reactions to infection.
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